Sep 2026· Zhonghua zhong liu za zhi [Chinese journal of oncology]· Vol 48 9, pp.
1147-1156
· 0 citations
Medicine
TL;DR
BBOX1-AS1 is highly expressed in NSCLC patients, and its high expression indicates a poor prognosis, and potential functional target genes and prognostic biomarkers for NSCLC are screened.
SGPP1 functions as a tumor suppressor gene in ESCC and may inhibit tumor progression by regulating UGT1A9/UGT2B28‑mediated metabolic pathways and serve as a prognostic biomarker and a potential therapeutic target in ESCC.
L. Su, L. Hou, Xue-Tao Han et al.· Oncology Report· 0 citations
Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by hyperglycemia, generating circulating glycated albumin (GA). The development and progression of liver cancer, and more specifically hepatocellular carcinoma (HCC), are increased in patients with T2D. To facilitate early diagnosis and appropriate...
The core pathological feature of type 2 diabetes mellitus (T2DM) is pancreatic β-cell failure; therefore, the identification of effective circulating biomarkers and molecular targets that regulate pancreatic β-cell homeostasis is of significant practical importance. As key regulatory molecules of gene expression, miRNA...
Background and Aims The objective of this research was to investigate the diagnostic and prognostic value, as well as the functional roles of miR-2116-3p in HCC. Methods We evaluated the expression level of miR-2116-3p using qRT-PCR. The diagnostic and prognostic implications of miR-2116-3p expression in plasma were in...
Qi-Tian Sun, Chang-Rong Ren, Zi-Yu Bai et al.· Journal of Hepatocellular Ca...· 0 citations
Simple Summary Patients with non-small-cell lung cancer can respond differently to platinum-based chemotherapy, highlighting the need for reliable biomarkers that can help predict disease outcomes and support treatment decisions. In this study, we evaluated a panel of six small RNA molecules, called microRNAs, in tumor...
M. Mortoglou, C. Papadaki, A. Boukouris et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.